×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| AARTI DRUGS LTD. | 5259.1 | 385.3 | 5145.4 | 4.22 | 3,568 | 23.4 |
| Dishman Carbogen Amcis Limited | 6879.7 | 46.3 | 6823.4 | 0.30 | 3463 | |
| Advanced Enzyme Technologies L | 1,767.97 | 388.76 | 1,691.12 | 3.36 | 3242 | 22.8 |
Aarti Drugs Limited, with Security Code 524348, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 624.8 | 625.5 | 696.4 | 591.6 | 577.5 | 538.2 | 559.5 | 492.9 | 543.0 | 514.5 |
| Expenses | 554.7 | 556.6 | 607.9 | 519.7 | 512.1 | 478.5 | 490.5 | 438.7 | 483.6 | 454.3 |
| Operating Profit | 70.2 | 69.0 | 88.5 | 71.9 | 65.4 | 59.7 | 69.1 | 54.2 | 59.5 | 60.3 |
| OPM % | 11.23% | 11.03% | 12.71% | 12.15% | 11.33% | 11.1% | 12.34% | 11% | 10.96% | 11.71% |
| Other Income | 0.1 | 1.0 | 0.9 | 0.7 | 0.7 | 1.7 | 1.1 | 0.1 | 0.4 | 11.4 |
| Interest | 8.3 | 9.1 | 8.4 | 7.8 | 7.6 | 6.8 | 8.1 | 7.5 | 7.2 | 7.6 |
| Depreciation | 11.9 | 11.9 | 11.7 | 11.8 | 11.8 | 11.8 | 12.3 | 11.7 | 11.9 | 12.0 |
| Profit before tax | 50.1 | 49.0 | 69.4 | 53.0 | 46.8 | 42.9 | 49.7 | 35.2 | 40.9 | 52.0 |
| Tax % | 27% | 25% | 23.4% | 25.5% | 26.2% | 26.2% | 27.3% | 23.5% | 25.7% | 25.9% |
| Net Profit | 36.6 | 36.7 | 53.2 | 39.5 | 34.6 | 31.6 | 36.1 | 26.9 | 30.4 | 38.5 |
| EPS in Rs | 3.95 | 3.96 | 5.74 | 4.27 | 3.75 | 3.44 | 3.93 | 2.93 | 3.33 | 4.22 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 622.0 | 687.7 | 664.0 | 742.4 | 661.1 | 641.5 | 605.9 | 620.0 | 555.3 | 598.3 |
| Expenses | 554.8 | 613.5 | 593.3 | 648.9 | 577.0 | 565.1 | 535.8 | 534.2 | 490.4 | 531.3 |
| Operating Profit | 67.1 | 74.3 | 70.7 | 93.5 | 84.1 | 76.5 | 70.1 | 85.8 | 65.0 | 67.1 |
| OPM % | 10.8% | 10.8% | 10.6% | 12.6% | 12.7% | 11.9% | 11.6% | 13.8% | 11.7% | 11.2% |
| Other Income | 0.3 | 0.1 | 1.0 | 0.9 | 0.6 | 0.7 | 1.7 | 1.1 | 1.1 | 1.5 |
| Interest | 6.8 | 8.5 | 9.4 | 8.6 | 8.5 | 8.3 | 7.6 | 9.1 | 8.7 | 8.9 |
| Depreciation | 12.5 | 12.7 | 12.6 | 12.5 | 12.6 | 12.6 | 12.7 | 13.6 | 13.4 | 13.7 |
| Profit before tax | 48.0 | 53.2 | 49.7 | 73.3 | 63.5 | 56.3 | 51.6 | 64.2 | 44.0 | 45.9 |
| Tax % | 27.6% | 27.2% | 26.2% | 23.3% | 24.5% | 29.6% | 28.8% | 26.3% | 24.4% | 23.8% |
| Net Profit | 34.8 | 38.7 | 36.7 | 56.2 | 48.0 | 39.6 | 36.7 | 47.3 | 33.3 | 35.0 |
| EPS in Rs | 3 | 4 | 3 | 6 | 5 | 4 | 3 | 5 | 3 | 3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | -18% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 18% |
| 3 Years: | -8% |
| 1 Year: | -27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | -15% |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 18% |
| 3 Years: | -8% |
| 1 Year: | -27% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|